Your Article Summary
See Latest ArticlesPsoriatic arthritis assessment and treatment update
Current Opinion in Rheumatology, 06/15/09
Mease PJ - Increasingly, PsA is being recognized as a distinct disease entity worthy of research regarding reliable assessment and focus on the development of effective and well tolerated therapies. A number of emerging treatments, predominantly biologics, have shown substantial efficacy and reasonable safety profiles in the treatment of multiple clinical domains of PsA, thus providing the option of either monotherapy or combination therapy approaches to disease treatment.
Related Articles
Psoriatic arthritis common in people with psoriasis
Internet Source, 11/06/09
Relevance Score: 70%
A sonographic spectrum of psoriatic arthritis: the five targets
Clinical Rheumatology, 11/03/09
Relevance Score: 70%
Update in treatment options for psoriatic arthritis
Expert Review of Clinical Immunology, 11/23/09
Relevance Score: 69%
Lack of association between angiotensin I-converting enzyme insertiondeletion polymorphism and psoriasis or psoriatic arthritis in Spain
International Journal of Dermatology, 11/30/09
Relevance Score: 68%
The double trouble of psoriatic arthritis
Internet Source, 11/18/09
Relevance Score: 68%
Today in Other Arthritis...keeping you current
Receive free subspecialty "5-minute updates" via email
A case of granulomatous mastitis with erythema nodosum and arthritis
Rheumatology International, 12/19/09
Better assessment of physical function: item improvement is neglected but essential
Arthritis Research & Therapy, 12/19/09
A case of juvenile idiopathic polyarticular arthritis complicated by IgA deficiency in 22q11 deletion syndrome
Rheumatology International, 12/19/09